Navigation Links
Artificial Ovaries Could Potentially Deliver Hormone Therapy
Date:3/29/2013

FRIDAY, March 29 (HealthDay News) -- It might be possible to create artificial ovaries in the laboratory to provide a more natural form of hormone replacement therapy (HRT) for women, researchers report.

As well as producing eggs, ovaries secrete hormones that are important for bone and heart health. Production of these hormones stops due to menopause, as well as surgical removal of the ovaries, chemotherapy and radiation treatments for certain types of cancer.

There are hormone replacement medications, but long-term use of the drugs is generally avoided due to the increased risk of heart disease and breast cancer, according to the authors of a new study published in the March issue of the journal Biomaterials.

In this study, a team from the Institute of Regenerative Medicine at Wake Forest Baptist Medical Center reported that ovaries created in the lab showed sustained release of the female sex hormones estrogen and progesterone.

"Our goal is to develop a tissue- or cell-based hormone therapy -- essentially an artificial ovary -- to deliver sex hormones in a more natural manner than drugs," study senior author Emmanuel Opara, a professor of regenerative medicine, said in a Wake Forest news release.

"A bioartificial ovary has the potential to secrete hormones in a natural way based on the body's needs, rather than the patient taking a specific dose of drugs each day," Opara explained.

The next research step -- evaluating the function of the ovarian structures in animals -- is already under way, Opara noted.

Commenting on the study, Dr. Tamer Yalcinkaya, an associate professor and section head of reproductive medicine at Wake Forest Baptist, said: "This research project is interesting because it offers hope to replace natural ovarian hormones in women with premature ovarian failure or in women going through menopause."

An artificial ovary "would bring certain advantages: It would eliminate pharmacokinetic variations of hormones when administered as drugs and would also allow body's feedback mechanisms to control the release of ovarian hormones," Yalcinkaya explained in the news release.

More information

The American Academy of Family Physicians has more about hormone replacement therapy.

-- Robert Preidt

SOURCE: Wake Forest Baptist Medical Center, news release, March 26, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Wearable artificial lung to be developed at Pitt through $3.4 million grant
2. Artificial Pancreas Worked Overnight on Kids With Type 1 Diabetes
3. Swine cells could power artificial liver
4. Hear This: 3-D Printing Creates Lifelike Artificial Ears
5. Artificial Organs (Medical Bionic Implants) Market is expected to grow at a CAGR of 7.1% & to reach $17.82 billion by 2017 - New Report by MarketsandMarkets
6. Artificial pancreas: The way of the future for treating type 1 diabetes
7. FDA: Dont Use Pradaxa Blood Thinner in Patients With Artificial Heart Valves
8. A leap forward in the quest to develop an artificial pancreas
9. Artificial butter flavoring ingredient linked to key Alzheimers disease process
10. Farmers tough on artificial limbs
11. Could Compound in Artificial Sweeteners Worsen Crohns Disease?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial Ovaries Could Potentially Deliver Hormone Therapy
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology: